173 related articles for article (PubMed ID: 30356125)
1. Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.
Watson RA; De La Peña H; Tsakok MT; Joseph J; Stoneham S; Shamash J; Joffe J; Mazhar D; Traill Z; Ho LP; Brand S; Protheroe AS
Br J Cancer; 2018 Oct; 119(9):1044-1051. PubMed ID: 30356125
[TBL] [Abstract][Full Text] [Related]
2. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
3. Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.
Necchi A; Miceli R; Oualla K; Sonpavde G; Giannatempo P; Raggi D; Nicolai N; Boffi R; Busia A; Mariani L; Salvioni R
Clin Genitourin Cancer; 2017 Apr; 15(2):213-220.e5. PubMed ID: 27692810
[TBL] [Abstract][Full Text] [Related]
4. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
5. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
6. [Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
Schummer C; Winkler Y; Tittelbach J; Grimm MO; Elsner P
Dtsch Med Wochenschr; 2014 Jan; 139(3):84-6. PubMed ID: 24399654
[TBL] [Abstract][Full Text] [Related]
7. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.
Kawai K; Akaza H
Expert Opin Drug Saf; 2003 Nov; 2(6):587-96. PubMed ID: 14585067
[TBL] [Abstract][Full Text] [Related]
9. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
[TBL] [Abstract][Full Text] [Related]
10. The effect of corticosteroid administration on bleomycin lung toxicity.
Jensen JL; Goel R; Venner PM
Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
12. Revisiting bleomycin from pathophysiology to safe clinical use.
Froudarakis M; Hatzimichael E; Kyriazopoulou L; Lagos K; Pappas P; Tzakos AG; Karavasilis V; Daliani D; Papandreou C; Briasoulis E
Crit Rev Oncol Hematol; 2013 Jul; 87(1):90-100. PubMed ID: 23312772
[TBL] [Abstract][Full Text] [Related]
13. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
14. Current Management of Disseminated Germ Cell Tumors.
Lavoie JM; Kollmannsberger CK
Urol Clin North Am; 2019 Aug; 46(3):377-388. PubMed ID: 31277732
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin in germ cell testicular tumors (GCTT).
Germa Lluch JR
Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
[No Abstract] [Full Text] [Related]
16. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
Bokemeyer C
J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
[No Abstract] [Full Text] [Related]
17. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
[TBL] [Abstract][Full Text] [Related]
18. Vascular toxicity following vinblastine, bleomycin, and cisplatin therapy for germ cell tumours.
Samuels BL; Vogelzang NJ; Kennedy BJ
Int J Androl; 1987 Feb; 10(1):363-9. PubMed ID: 2438227
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin-Induced Flagellate Dermatitis.
Imhof RL; Tollefson MM
Mayo Clin Proc; 2019 Feb; 94(2):371-372. PubMed ID: 30711138
[No Abstract] [Full Text] [Related]
20. Cerebrovascular accident after chemotherapy for testicular cancer.
Karagoz B; Bilgi O; Akyol I; Ozgun A; Turken O; Kandemir EG
Mil Med; 2009 Mar; 174(3):320-1. PubMed ID: 19354100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
